Catheter Precision, Inc. VTAK

0.15 (0.01) (6.25%) as of 25 Sep
Market cap
$3.0M
P/E
0.0×
Growth Flags show if company had growth for consecutive years
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
2.41 3.50 4.97 340.74 451.04 54.51 3.73 2,785,263.50 0.00 0.00
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/Operating CF
(1.31) (0.51) (1.16) (2.14) (1.82) (1.50) (2.80) (2,074,936.75) (10,883,013.27) (10,883,013.27)
P/B ratio
0.30 0.12 0.10 0.70 0.76 0.67 0.81 261,260.68 0.00 0.00
Price to Tangible BV
0.00 0.00 0.00 0.70 0.76 0.67 0.81 261,260.68 0.00 0.00
EV/Sales
6.13 0.50 (2.78) (385.84) (104.65) (30.68) (0.44) 2,785,253.36 0.00 0.00
EV/EBITDA
0.00 0.00 0.02 0.28 0.09 0.24 0.06 0.00 0.00 0.00
EV/Operating CF
(0.60) (0.02) 0.06 0.32 0.09 0.28 0.10 (941,610.67) (3,354,230.13) (3,354,230.13)
EV/FCF
(0.60) (0.02) 0.06 0.33 0.09 0.28 0.10 (912,903.63) (3,136,383.98) (3,136,383.98)
Quick Ratio
0.06 1.32 1.50 2.09 2.80 3.08 4.60 11.03 3.32 1.59
Current Ratio
0.10 1.48 1.68 2.22 3.17 3.56 5.28 11.64 3.81 1.96
Net Debt/EBITDA
(0.16) 0.14 0.05 0.60 0.46 0.67 0.54 2.08 0.47 0.93
Debt/Assets
19.41% 5.62% 0.00% 0.00% 10.76% 5.51% 1.27% 1.15% 0.56% 1.83%
Debt/Equity
0.46 0.13 0.00 0.00 0.17 0.09 0.02 0.01 (0.01) (0.28)
Asset Turnover
0.04 0.01 0.02 0.00 0.00 0.01 0.12 0.15 0.69 0.70
Operating CF/Net income
0.48 0.43 0.29 0.84 1.10 0.79 0.58 0.60 0.31 0.45
Capex/Depreciation
(0.01) (0.03) (0.04) 0.05 0.21 (0.03) (0.15) (0.93) (2.51) 0.00
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(186.69%) (132.33%) (468.74%) (234.29%) (144.00%) (132.77%) (114.08%) (104.36%) 444.40% 105.12%
ROA
(78.77%) (74.53%) (300.06%) (141.84%) (92.03%) (93.00%) (96.44%) (72.29%) (207.64%) (49.11%)
ROIC
(137.06%) (67.28%) (276.97%) 0.00% (2,050.59%) 0.00% (1,152.39%) (601.08%) 0.00% 0.00%
Return on Tangible Assets
497.63% (1,890.81%) (4,057.53%) (290.12%) (185.59%) (161.02%) (166.37%) (45.31%) (207.34%) (135.37%)
Average Days of Receivables
69.08 60.83 113.13 0.00 348.41 33.82 39.85 77.00 32.15 24.00
Research and Development Expense of Revenue
105.25% 64.76% 107.47% 45,657.14% 55,695.45% 3,457.53% 62.93% 44.37% 76.97% 28.70%
Selling, General and Administrative Expense of Revenue
1,474.36% 2,702.14% 3,873.76% 116,071.43% 70,340.91% 9,472.20% 716.06% 486.42% 254.63% 89.04%
Intangible Assets out of Total Assets
0.96 0.87 0.86 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
41.27% 12.86% 275.34% 3,192.86% 10,168.18% 1,576.06% 327.03% 235.38% 216.46% 0.00%
Graham Net Nets
(4.46) (8.66) (2.45) 1.43 0.94 1.09 0.93 0.00 0.00 0.00
Graham Number
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Yield
(1,019.04%) (1,133.15%) (3,210.89%) (407.59%) (363.04%) (425.69%) (63.76%) 0.00% (8.66%) (8.66%)
Free Cash Flow Yield
(420.38%) (635.72%) (942.22%) (347.65%) (263.12%) (200.97%) (124.61%) 0.00% 0.00% 0.00%
Revenue per Share
0.76 2.44 15.29 2.59 44.00 1,295.00 71,990.00 0.68 0.78 11.77
Operating CF per Share
(7.68) (53.96) (713.46) (4,179.26) (55,250.00) (141,520.00) (331,730.00) (2.01) (0.73) (3.72)
Capex per Share
(0.02) (0.39) (2.63) 3.89 658.00 (335.00) (2,680.00) (0.06) (0.07) 0.00
Free Cash Flow per Share
(7.69) (54.35) (716.09) (4,175.37) (54,592.00) (141,855.00) (334,410.00) (2.07) (0.80) (3.72)
Cash per Share
0.08 16.72 123.36 2,936.85 30,090.00 119,530.00 305,770.00 6.97 1.09 7.72
Shareholders Equity per Share
6.15 68.43 733.32 1,714.81 27,346.00 105,735.00 331,500.00 7.23 (1.01) (0.75)
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.00 0.00
Book value per Share
6.15 68.43 733.32 1,714.81 27,346.00 105,735.00 331,500.00 7.23 (1.01) (0.75)
Free Cash Flow
(8.31) (9.34) (20.69) (22.55) (27.30) (28.37) (33.44) (19.09) (6.07) (1.89)
Working Capital
(3.52) 1.06 1.69 9.26 11.70 19.86 29.19 63.28 7.41 2.60
Capital Expenditures
(0.02) (0.07) (0.08) 0.02 0.33 (0.07) (0.27) (0.58) (0.55) (0.21)
Net Current Asset Value
(8.82) (12.72) (5.38) 9.26 9.72 15.33 25.07 61.90 (8.84) (0.91)
EV/EBIT
0.00 0.00 0.02 0.27 0.08 0.22 0.06 0.00 0.00 0.00
Capex to Sales
0.02 0.16 0.17 (1.50) (14.95) 0.26 0.04 0.09 0.09 0.00
Net Profit Margin
(2,098.05%) (5,190.71%) (16,147.51%) (191,892.86%) (113,954.55%) (13,916.99%) (791.18%) (492.76%) (302.64%) (70.31%)
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
33.05 23.18 29.64 0.00 0.87 0.94 0.35 0.13 0.19 0.19
Cash ROIC
(85.16%) (57.82%) (83.56%) (89.84%) (95.00%) (65.74%) (59.46%) (17.64%) (975.47%) (65.57%)
Accounts Receivable Turnover
7.28 4.06 5.59 0.00 0.98 0.64 6.84 6.81 12.90 13.13
Accounts Payable Turnover
0.07 0.12 0.11 0.30 2.14 2.17 6.66 5.42 9.27 6.98
Inventory Turnover
1.06 1.09 0.06 0.00 1.67 1.19 3.63 2.55 4.03 3.04
Average Days of Payables
8,644.13 1,998.81 5,645.33 208.57 231.17 79.15 63.18 97.63 37.33 55.02
Days of Inventory on Hand
498.25 286.79 535.33 0.00 230.70 147.38 114.53 181.98 104.81 101.20
Average Receivables
0.11 0.10 0.08 — 0.02 0.41 1.05 0.92 0.46 0.46
Average Payables
0.86 0.35 0.28 0.54 0.73 1.00 1.33 0.78 0.45 0.45
Average Inventory
0.06 0.04 0.52 — 0.93 1.83 2.44 1.65 1.03 1.03
Average Assets
21.82 29.25 23.79 18.94 27.24 38.76 59.06 42.65 8.56 8.56
Average Common Equity
9.20 16.48 15.23 11.47 17.41 27.15 49.93 29.55 (4.00) (4.00)

Fold the line items

Columns are period end dates